Skip to main content
. 2020 Aug 7;21(3):1470320320945137. doi: 10.1177/1470320320945137

Table 2.

Medication use by class in the CKD-MIT by CKD stage.

Medication class CKD stage 3A (eGFR 45–59 mL/min/1.73 m2), n/N=49/141 CKD stage 3B (eGFR 30–44 mL/min/1.73 m2), n/N=52/141 CKD stage 4/5 (eGFR 15–29 mL/min/1.73 m2), n/N=40/141 Total combined medication use in CKD-MIT, N=141
n % n % n % n %
Antihypertensive agent 45 92 46 89 39 98 130 92
ACE inhibitor/ARB 29 59 19 37 17 43 65 46
Diuretic 21 43 31 60 31 78 83 59
 Loop 19 39 24 46 28 70 71 50
 Thiazide 4 8 6 12 6 15 16 11
 Potassium sparing 5 10 7 14 2 5 14 10
Beta blocker 21 43 28 54 20 50 69 49
Calcium channel blocker 13 27 13 25 18 45 44 31
 Dihydropyridine 7 14 9 17 16 40 32 23
 Non-dihydropyridine 6 12 5 10 3 8 14 10
Other antihypertensive 0 0 7 14 6 15 13 9
Other OTC/herbal 32 65 41 79 32 80 105 74
Platelet inhibitor 35 71 31 60 23 58 89 63
 Aspirin 33 67 26 50 21 53 80 57
 Other platelet inhibitor 6 12 17 33 6 15 29 21
Statin 29 59 35 67 22 55 86 61
Gastrointestinal agent 27 55 29 56 21 53 77 55
 Proton pump inhibitor (PPI) 17 35 22 42 14 35 53 38
 Other gastrointestinal agent 17 35 15 29 10 25 42 30
Antihyperglycemic agent 18 37 29 56 25 63 72 51
 Insulin 13 27 19 37 21 53 53 38
 Oral antihyperglycemic agent 10 20 16 31 6 15 32 23
 Sulfonylurea 4 8 7 14 5 13 16 11
 Metformin 7 14 6 12 1 3 14 10
 DPP-4 Inhibitor 2 4 2 4 0 0 4 3
 Thiazolidinedione 0 0 2 4 0 0 2 1
 GLP-1 receptor agonist 1 2 1 2 0 0 2 1
Vitamin D 20 41 28 54 24 60 72 51
Psychoactive agents 24 49 28 54 17 43 69 49
 Antidepressant 18 37 20 39 10 25 48 34
 Anticonvulsant 8 16 9 17 5 13 22 16
 Anxiolytic 8 16 4 8 5 13 17 12
 Insomnia medication 3 6 4 8 0 0 7 5
 Other psychoactive agent 1 2 0 0 0 0 1 <1
Opioid agonist 16 33 19 37 11 28 46 33
Acetaminophen 13 27 21 40 10 25 44 31
Thyroid supplement 13 27 13 25 11 28 37 26
Antibiotic agent 15 31 10 19 11 28 36 26
Anticoagulant 11 22 14 27 11 28 36 26
 Warfarin 9 18 11 21 10 25 30 21
 Direct oral anticoagulant 2 4 3 6 0 0 5 4
 Heparin 0 0 0 0 1 3 1 <1
 Low molecular weight heparin 0 0 0 0 1 3 1 <1
Uric acid lowering agent 13 27 9 17 13 33 35 25
Iron supplements 10 20 13 25 11 28 34 24
Nitrate 10 20 13 25 7 18 30 21
Prescription phosphate binder 0 0 2 4 3 8 12 9
Parkinson’s disease medication 3 6 2 4 1 3 6 4
NSAID 2 4 3 6 0 0 5 4
Erythropoietin stimulating agent 0 0 1 2 1 3 2 1
Potassium binder 0 0 1 2 0 0 1 <1
Dementia medication 0 0 1 2 0 0 1 <1
Anti-neoplastic 0 0 1 2 0 0 1 <1

ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker; DPP-4: dipeptidyl peptidase-4; GLP-1: glucagon-like peptide-1; NSAID: nonsteroidal anti-inflammatory drug.